2023 Annual Meeting | P2 - Poster Session 2

Date Sunday 04/23/23

Time 11:45 AM - 12:45 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Sleep, Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, ��ɫ��, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology, Neuro-ophthalmology/Neuro-otology, Neuro Trauma and Critical Care

CME Available 0.00 CME credit

Event Timeline
11:45 AM - 12:45 PM EST	Abstract	9-001 - Long-term Remission and Resolution of Epilepsy following Surgery for Drug Resistant Lesional Temporal Lobe Epilepsy. Sita J. Sattaluri
11:45 AM - 12:45 PM EST	Abstract	9-002 - Outcome after laser interstitial thermal therapy (LITT) in patients with drug-resistant epilepsy Emily In
11:45 AM - 12:45 PM EST	Abstract	9-003 - Lesion-related epilepsy maps to a common brain network Frederic Schaper, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	9-004 - Network metrics to localize the Seizure Onset Zone: A Directed Functional Connectivity Study Using MEG Data Natascha Cardoso Da Fonseca, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	9-005 - Initial Clinical Experience with Thin-Film Polyimide Subdural Electrodes for Seizure Monitoring Brigitte Reina, MD
11:45 AM - 12:45 PM EST	Abstract	9-006 - External Validation of Novel Method of Seizure Onset Zone Localization Based on Neural Resonance Derrick Barnagian, MD, BS
11:45 AM - 12:45 PM EST	Abstract	9-007 - Characteristics and Surgical Outcomes in a Cohort of Patients with Epilepsy and encephaloceles Daniel Mafla Delgado, Sr., MD
11:45 AM - 12:45 PM EST	Abstract	9-008 - Two Distinct Networks are Affected by Mesial Temporal Lobe Epilepsy Jonathan M. Towne
11:45 AM - 12:45 PM EST	Abstract	9-009 - Yield of Stereotactic Electroencephalography for evaluation of Drug Resistant Focal Epilepsy: Single-Center Experience. Cindy Luan, MD
11:45 AM - 12:45 PM EST	Abstract	9-010 - Ipsilateral Arm Movement related to Extratemporal Premotor Cortex Seizures with Secondary Spread to the Limbic Network seen on Pre-Surgical Stereotactic Electroencephalogram Gaurav Kathuria, MD
11:45 AM - 12:45 PM EST	Abstract	9-011 - Survival Analysis of Accidents Confirms Reduction After Surgery in a Group of 439 Individuals with Temporal Lobe Epilepsy and Hippocampal Atrophy Aline F. Dias, MD, Other
11:45 AM - 12:45 PM EST	Abstract	9-012 - Ictal Single Photon Emission Computed Tomography (SPECT) In Patients with Focal Aware Seizure without Ictal Electroencephalographic Changes: A Single Center Experience Saniya Pervin, MD
11:45 AM - 12:45 PM EST	Abstract	15-001 - The Completion of a PGY-1 Neurology Bootcamp Leads to Increased Trainee Knowledge and Confidence in Neurologic Emergencies Management and Procedural Skills Carol Swetlik, MD
11:45 AM - 12:45 PM EST	Abstract	15-002 - Neurology 101 for Medicine Residents: A Straightforward and Effective Lecture Erafat Rehim, MD
11:45 AM - 12:45 PM EST	Abstract	15-004 - Child Neurology Residency Survey of Psychogenic Nonepileptic Seizure ��ɫ�� Dara V. Albert, DO, FAAN
11:45 AM - 12:45 PM EST	Abstract	15-005 - Developing a Curriculum for Functional Neurological Disorder in Neurology Training Sara A. Finkelstein, MD
11:45 AM - 12:45 PM EST	Abstract	15-006 - Improving Residents’ Knowledge and Interest in Outpatient Neurology through an Interactive, Discussion-Based, Patient-Centered Didactic Series Galina Gheihman, MD
11:45 AM - 12:45 PM EST	Abstract	3-001 - Regulation of the PD-1/PD-L1 axis in relapsing-remitting Multiple Sclerosis Thanos Tsaktanis, MD
11:45 AM - 12:45 PM EST	Abstract	3-002 - Long-term Culture of Cerebral Organoid Reveals Disruption of Glial Cell Differentiation and Glutamate Excitotoxicity in Multiple Sclerosis. Tanmay Mehta
11:45 AM - 12:45 PM EST	Abstract	3-003 - A Potential Protective Role of Nurr1 in Multiple Sclerosis Motor Cortex Gina L. Hadley, MD
11:45 AM - 12:45 PM EST	Abstract	3-005 - Biological roles of myeloid cell subsets during CNS inflammation Navid Manouchehri, MD
11:45 AM - 12:45 PM EST	Abstract	3-006 - Astrocyte-derived HB-EGF promotes recovery from autoimmune CNS inflammation and is a potential target in progressive disease Mathias Linnerbauer
11:45 AM - 12:45 PM EST	Abstract	3-007 - Aldh1l1-cre/ERT2 promoter drives flox-mediated recombination in peripheral immune cells in addition to astrocytes Sam H. Horng, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	3-008 - Gut microbiota composition in untreated people with relapsing-remitting and secondary-progressive Multiple Sclerosis Radu Tanasescu, MD, PhD, FAAN
11:45 AM - 12:45 PM EST	Abstract	3-009 - Single Cell Transcriptomics of Myeloid Cells in Black Americans with Multiple Sclerosis Jeremy M. Bingen
11:45 AM - 12:45 PM EST	Abstract	3-010 - Metabolomic Profiling of Multiple Sclerosis Lesions and Periplaque White Matter Demonstrates Extensive Changes in Lipid Metabolism Dimitrios C. Ladakis, MD
11:45 AM - 12:45 PM EST	Abstract	3-011 - Conserved Transcriptional Signatures of Microglia in Health and Disease Victor H. Salinas
11:45 AM - 12:45 PM EST	Abstract	3-012 - Evaluating the Effect of a Bruton’s Tyrosine Kinase Inhibitor in a Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Timothy J. Turner
11:45 AM - 12:45 PM EST	Abstract	3-013 - Remibrutinib Inhibits Neuroinflammation Driven by B Cells and Myeloid Cells in Preclinical Models of Multiple Sclerosis Bernd C. Kieseier, MD
11:45 AM - 12:45 PM EST	Abstract	3-014 - Pharmacological inhibition of FGFR by infigratinib reduces lipids associated with neurodegeneration in MOG35-55-induced EAE Martin Berghoff, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	3-015 - Interferome perturbation of human brain organoids induces progenitor and neuronal dysfunction seen in multiple sclerosis and autism
11:45 AM - 12:45 PM EST	Abstract	3-016 - Tracking the immune response to SARS-CoV-2 mRNA booster vaccination in an open-label multicenter study in participants with relapsing multiple sclerosis treated with ofatumumab s.c. (KYRIOS clinical trial) Cordula Weiss, PhD
11:45 AM - 12:45 PM EST	Abstract	3-017 - Immune Response Following COVID-19 Vaccination (mRNA or Non-mRNA) in Patients with Relapsing Multiple Sclerosis Treated with the Bruton’s Tyrosine Kinase Inhibitor Evobrutinib: An Update Elise Drouin, PhD
11:45 AM - 12:45 PM EST	Abstract	3-018 - Serologic Response and Clinical Outcomes of SARS-CoV-2 Infection and Vaccination in Ozanimod-Treated Participants With Relapsing Multiple Sclerosis Sarah Harris
11:45 AM - 12:45 PM EST	Abstract	12-001 - MRI negative Varicella zoster virus (VZV) plexopathy in a young man with history of malignancy Sedat Gul, MD
11:45 AM - 12:45 PM EST	Abstract	12-004 - Neurology: The Cerebral and Corporeal Specialty Sumita M. Strander
11:45 AM - 12:45 PM EST	Abstract	12-005 - The Neurologist's Dragon Trenley Anderson
11:45 AM - 12:45 PM EST	Abstract	12-006 - Sclerose en Plaques: A Tribute to the History of Multiple Sclerosis and Charcot's Role in Precision Medicine Today Zabrina G. Reyes, MD
11:45 AM - 12:45 PM EST	Abstract	12-007 - Rolling With The Punches Alexandra Miner
11:45 AM - 12:45 PM EST	Abstract	6-001 - Ischemic Stroke due to Intracerebral Steal from Calvarial Metastasis: a Case Report Anjali Murthy
11:45 AM - 12:45 PM EST	Abstract	6-002 - A Rare Mutation Associated with Cerebral Arteriopathy with Subcortical Infarct and Leukoencephalopathy (CADASIL) Claire E. Delpirou Nouh, MD
11:45 AM - 12:45 PM EST	Abstract	6-003 - Transient Perivascular Inflammation of the Carotid Artery (TIPIC) Syndrome after Breast Implant Surgery Lekshmi Peringassery Sateesh, MD
11:45 AM - 12:45 PM EST	Abstract	6-004 - A Case Report of Pituitary Apoplexy and Acute Ischemic Stroke Sukhmani Sandhu, MD
11:45 AM - 12:45 PM EST	Abstract	6-005 - Lemierre syndrome associated Cavernous Sinus Thrombosis and Development of Internal Carotid Artery Narrowing: A Case Report and Review of Literature Jiping Zhou, MD, MPH
11:45 AM - 12:45 PM EST	Abstract	6-006 - Non-traumatic Cerebral Fat Emboli Syndrome in a patient with Sickle Cell Crisis Yoram Ebrahimi, MD
11:45 AM - 12:45 PM EST	Abstract	6-007 - Embolic Stroke Following Intravenous Ozone Therapy Atef Kokash, DO
11:45 AM - 12:45 PM EST	Abstract	6-008 - Heart-Shaped infarct: Devastating Bilateral Medial Medullary Strokes Due to Amphetamine abuse Muhammad I. Yousaf, MD
11:45 AM - 12:45 PM EST	Abstract	6-009 - Spontaneous Paradoxical Improvement of Motor Function after a Second Stroke Yookyeong Baek, MD
11:45 AM - 12:45 PM EST	Abstract	6-010 - Asystole, A Rare Cardiac Complication of Lateral Medullary Infarction: Case report and Literature Review. Laura Gutierrez Quiceno, MD
11:45 AM - 12:45 PM EST	Abstract	6-011 - Testosterone Therapy in a Transgender Male Patient as a cause of Acute Ischemic Stroke Christina Tan, MD
11:45 AM - 12:45 PM EST	Abstract	6-012 - Posterior Reversible Encephalopathy Syndrome (PRES), Hypoxic Injury and Stroke: A Sequelae of Bath Salt Inhalation? Muhammad I. Yousaf, MD
11:45 AM - 12:45 PM EST	Abstract	6-014 - Persistent Hiccups Following Thalamic Hemorrhage Vikram Shivkumar, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	6-015 - Transient Cortical Blindness Following Cerebral Angiography: A Case Report Jennifer Harris, MD
11:45 AM - 12:45 PM EST	Abstract	6-016 - Intravascular CNS Lymphoma: An elusive diagnosis Hemani Ticku, MD
11:45 AM - 12:45 PM EST	Abstract	6-017 - CHANTER Syndrome: A Rare Cause of Encephalopathy and Ischemic Lesions James Hiana, MD
11:45 AM - 12:45 PM EST	Abstract	6-018 - Concomitant occurrence of Cerebral Hyperperfusion Syndrome (CHS) and Reversible Cerebral Vasoconstriction Syndrome (RCVS) after right Carotid Endarterectomy (CEA) Muhammad W. Anjum, MD
11:45 AM - 12:45 PM EST	Abstract	6-019 - Cardiac Papillary fibroelastoma (CPF): a rare underrecognized etiology of cardioembolic stroke. Mohamed M. Eldokmak, MD
11:45 AM - 12:45 PM EST	Abstract	6-020 - A rare presentation of a longitudinally extensive spinal cord lesion: a S5 Sacral Dural Venous Fistula Isabelle Hunt, MD
11:45 AM - 12:45 PM EST	Abstract	6-021 - Centenarians with Cerebrovascular Disease: 38 Patients from a Single Center. How much do we know? What can we improve? Roxana M. Dragomir, MD
11:45 AM - 12:45 PM EST	Abstract	6-022 - Case Series of Ischemic Stroke occurring in Male- to- Female Transgender population on Gender - Affirming Hormonal Therapy and Review of the Literature Marina Giovannini, MD
11:45 AM - 12:45 PM EST	Abstract	6-023 - The Global Prevalence and Incidence of Amyotrophic Lateral Sclerosis: A Systematic Review Maryam Oskoui, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	6-024 - Greater Blood Heavy Metal Levels in the Participants of National ALS Biorepository Compared to the Participants of National Health And Nutrition Examination Survey Moon Han, PhD
11:45 AM - 12:45 PM EST	Abstract	6-025 - Environmental Risk Factors for Amyotrophic Lateral Sclerosis: A Case–Control Study in Canada and France Marie Beaudin, MD
11:45 AM - 12:45 PM EST	Abstract	6-026 - Real-World Data on the Incidence and Risk of Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination; A Prospective Surveillance Study Jin Myoung Seok, MD
11:45 AM - 12:45 PM EST	Abstract	6-027 - Epidemiology of Antibody-positive Myasthenia Gravis in Sardinia, Italy Pietro Zara, MD
11:45 AM - 12:45 PM EST	Abstract	6-028 - Age and Sex Distributions of MOG-IgG and AQP4-IgG Positive Sera from a Large Neuroimmunology Laboratory Database Nisa Vorasoot, MD
11:45 AM - 12:45 PM EST	Abstract	6-029 - Modifiable Risk Factors of COVID-19 in Patients with Multiple Sclerosis: A Single-Centre Case-Control Study Federico Montini
11:45 AM - 12:45 PM EST	Abstract	6-030 - Life’s Simple 7 and the Risk of Dementia among Women Pamela Rist, PhD
11:45 AM - 12:45 PM EST	Abstract	6-031 - Prevalence of Peripheral Nervous System Involvement in Adult Leukodystrophies Al-alya Alsabah, MD
11:45 AM - 12:45 PM EST	Abstract	6-032 - Change In Fall Risk-Increasing Drug Use Among Individuals with Parkinson Disease Before and After a Serious Injury Thanh Phuong Pham Nguyen, PharmD, MBA, MSCE
11:45 AM - 12:45 PM EST	Abstract	7-001 - Clinical Outcomes of Older Persons and Persons With Dementia Admitted for Coronavirus Disease 2019: Findings From the Philippine CORONA Study Bernadeth Lyn C. Piamonte, MD
11:45 AM - 12:45 PM EST	Abstract	7-002 - Precision Neurology for Dementia Joshua M. Shulman, MD, PhD, FAAN
11:45 AM - 12:45 PM EST	Abstract	7-003 - What Comes First: The Diagnosis or the Pill? Evidence from Alzheimer’s Disease Population Helen Trenz
11:45 AM - 12:45 PM EST	Abstract	7-004 - Epileptic Amnesia as an Alzheimer’s Disease Mimic Karan Philip, MBBS
11:45 AM - 12:45 PM EST	Abstract	7-005 - Practice Implications of Patterns of Healthcare Utilization before and after Alzheimer’s Disease diagnosis Lauren R. Moo, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	7-006 - Creation of a Memory Disorders Clinic Biorepository to Characterize a Clinic Population and Accurately Refer to Research Studies
11:45 AM - 12:45 PM EST	Abstract	7-008 - Depression and Dementia Risk: A Population-Based Cohort Study in Denmark Holly Elser, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	7-009 - Causes of Rapidly Progressive Dementia in a Prospectively Accrued Cohort Gregory S. Day, MD, MSc, FAAN
11:45 AM - 12:45 PM EST	Abstract	7-010 - Unusual Presentations Accentuating the Diagnostic Confusion of CJD Muhammad Bhatti, MD
11:45 AM - 12:45 PM EST	Abstract	1-001 - Critically-Elevated Interleukin-6 (IL-6): A Prognostic Biomarker for Post-Acute Sequelae of COVID-19 (PASC)? Ronak U. Trivedi
11:45 AM - 12:45 PM EST	Abstract	1-002 - Edema to Hematoma Ratio is Elevated in COVID-19 ICH Patients Justin L. Sim, MD
11:45 AM - 12:45 PM EST	Abstract	1-003 - A Survey of Burnout among Neurocritical Care Practitioners Pakinam Aboutaleb, MD
11:45 AM - 12:45 PM EST	Abstract	1-004 - Reversible Cerebral Vasoconstriction Syndrome (RCVS) After COVID-19 Vaccination: An Analysis of VAERS Bahadar S. Srichawla, DO, MS
11:45 AM - 12:45 PM EST	Abstract	1-005 - Mechanical Angioplasty with Comaneci for the Treatment Refractory Vasospasm Secondary to Coccidioidal Meningits Hisham Salahuddin, MD
11:45 AM - 12:45 PM EST	Abstract	1-006 - Wernicke’s Encephalopathy Preceded by COVID-19 Infection: A Case Report Victor Wang, MD
11:45 AM - 12:45 PM EST	Abstract	10-001 - Burden of Myasthenia Gravis Based on Sentiment Analysis of Patients’ Digital Conversations Caroline Brethenoux
11:45 AM - 12:45 PM EST	Abstract	10-002 - The clinical and genetic characteristics of 17 cases with Congenital Myasthenic Syndrome: Data from a single center Gulshan Yunisova, MD
11:45 AM - 12:45 PM EST	Abstract	10-003 - VAMP-1 associated congenital myasthenic syndrome: a demonstrative case with response to low-dose pyridostigmine Eleni Drakou, MD
11:45 AM - 12:45 PM EST	Abstract	10-004 - Iron Metabolism in Non-anemic Myasthenia Gravis Patients: A Cohort Study Ke Li, MD
11:45 AM - 12:45 PM EST	Abstract	10-005 - Long-Term Efficacy of Non-steroid Immunosuppressive Agents in Anti-Muscle-Specific Kinase Positive Myasthenia Gravis Patients: A Prospective Study Ying Tan, MD
11:45 AM - 12:45 PM EST	Abstract	10-006 - Effect of COVID-19 on Myasthenia Gravis Sukhmani Sandhu, MD
11:45 AM - 12:45 PM EST	Abstract	10-007 - Associations Between Clinical Severity, Serological Testing, and Electrophysiological Profiles in Patients with Myasthenia Gravis Ladan Bigdeli
11:45 AM - 12:45 PM EST	Abstract	10-008 - Risk of Infection in Patients with Myasthenia Gravis With and Without Thymoma Katherine M. Clifford, MD
11:45 AM - 12:45 PM EST	Abstract	10-009 - Weight Loss and Disease Progression in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis Ikjae Lee, MD
11:45 AM - 12:45 PM EST	Abstract	10-010 - Treatment Effects Among Patients with Type 2 and Type 3 SMA Directly Reported by Patients and Caregivers from the TOPAZ Clinical Trial Scott Baver
11:45 AM - 12:45 PM EST	Abstract	10-011 - Assessment of Transition Plan Implementation and Provider Engagement Amongst Adults Affected by Spinal Muscular Atrophy (SMA) Lauren E. Eisenman, Other
11:45 AM - 12:45 PM EST	Abstract	10-012 - Comparing Spinal Muscular Atrophy (SMA) outcomes between a patient-reported membership database and a clinical data registry Lisa Belter
11:45 AM - 12:45 PM EST	Abstract	10-013 - The Use of Onasemnogene-abeparvovec at 33 weeks’ gestation in Spinal Muscular Atrophy with One Copy of SMN2 Aparna Ajjarapu
11:45 AM - 12:45 PM EST	Abstract	10-014 - Cervical Spinal Cord Gray Matter Atrophy as an Emerging Imaging Marker in Spinal Muscular Atrophy Maria Janina Wendebourg, MD
11:45 AM - 12:45 PM EST	Abstract	10-015 - Single Center Experience of Nusinersen and Risdiplam in Adult SMA patients Akhil Shivaprasad, MBBS
11:45 AM - 12:45 PM EST	Abstract	4-001 - Seizures as the initial manifestation of Idiopathic Intracranial Hypertension Walid Bouthour, MD
11:45 AM - 12:45 PM EST	Abstract	4-002 - No Association Between Non-arteritic Anterior Ischemic Optic Neuropathy and COVID-19 Vaccination Nicholas J. Bellacicco, DO
11:45 AM - 12:45 PM EST	Abstract	4-004 - Optic nerve T2-hyperintensity: a nonspecific marker of optic nerve damage Fernando Labella Alvarez, MD
11:45 AM - 12:45 PM EST	Abstract	4-005 - MICK (Mobile Integrated Cognitive Kit) App: Feasibility of an Accessible Tablet-Based Rapid Picture and Number Naming Task for Concussion Assessment in a Youth Ice Hockey League Sara W. Hyman
11:45 AM - 12:45 PM EST	Abstract	4-006 - Multi-registry Analysis of Patients with Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO) to Improve Capture of Demographic Data and Compare Visual Outcomes Heather Moss, MD, PhD, FAAN
11:45 AM - 12:45 PM EST	Abstract	4-007 - Retina and optic nerve diffusion restriction in acute central retinal artery occlusion Ehab Y. Harahsheh, MBBS
11:45 AM - 12:45 PM EST	Abstract	4-008 - Corneal Confocal Microscopy Demonstrates No Evidence of Small Nerve Fiber Pathology in Obese Children and Adolescents Farah Wahbeh, MD
11:45 AM - 12:45 PM EST	Abstract	4-009 - Select Patients with High-Risk IIH May Be Managed with Medical Therapy Alone Jeffrey Gluckstein, MD
11:45 AM - 12:45 PM EST	Abstract	4-010 - The Unmet Challenge of Diagnosing and Treating Photophobia in Children Sarah Shapiro
11:45 AM - 12:45 PM EST	Abstract	4-011 - Smell the Rainbow: Olfactory Intensity Changes Color, not Luminescence in a Synesthete Sunjeet Brar
11:45 AM - 12:45 PM EST	Abstract	4-012 - Clues on Optical Coherence Tomography Leading to Diagnosis of Primary CNS Lymphoma Negar Moheb, MD
11:45 AM - 12:45 PM EST	Abstract	13-001 - Acute Cerebellar Stroke of Unclear Etiology Complicated by Lemierre’s Disease and Papillary Thyroid Carcinoma Stacey N. Ho, MD
11:45 AM - 12:45 PM EST	Abstract	13-002 - Neurological manifestations of scrub typhus: Encephalitis and Acute Inflammatory Demyelinating Polyneuropathy (AIDP) Tina Sood
11:45 AM - 12:45 PM EST	Abstract	13-003 - From (Cat) Scratch: A Unique Presentation of CNS Bartonella Infection Wilson E. Rodriguez, MD
11:45 AM - 12:45 PM EST	Abstract	13-004 - Sensorineural Hearing Loss From Capnocytophaga canimorsus Meningitis in an Immunocompetent Patient Manny Villar
11:45 AM - 12:45 PM EST	Abstract	13-005 - First Case Report of Bacteroides Thetaiotaomicron Cerebral Abscess after Cholesteatoma Resection Stephanie McGovern, NP
11:45 AM - 12:45 PM EST	Abstract	13-006 - Postpartum Listeria Meningitis: A Case Report Rui T. Tang, MD
11:45 AM - 12:45 PM EST	Abstract	13-007 - A Case of Oral Flora Related Carotid Vasculitis Cory P. Hackmyer, DO
11:45 AM - 12:45 PM EST	Abstract	5-001 - P2B001 significantly reduced risk of daytime sleepiness: results from a randomized controlled phase 3 trial with active pramipexole arm in early Parkinson’s disease (PD) Cheryl Fitzer-Attas, PhD
11:45 AM - 12:45 PM EST	Abstract	5-002 - Clinical trial protocol: TRANSCEND 1 – an observational study of patients with moderate Parkinson’s disease
11:45 AM - 12:45 PM EST	Abstract	5-004 - Relative bioavailability of levodopa administered as a subcutaneous infusion with ND0612 versus oral immediate-release levodopa/carbidopa tablets Liat Adar
11:45 AM - 12:45 PM EST	Abstract	5-005 - The Phase 2, Randomized, Placebo-controlled PRECEDENT Trial of SAGE-718 in Patients With Parkinson's Disease Cognitive Impairment: Clinical Trial in Progress Amy E. Bullock, PhD
11:45 AM - 12:45 PM EST	Abstract	5-006 - Characterizing a Parkinson's Disease Population Inadequately Controlled by Oral Therapy: Baseline Characteristics of the Phase 3 Clinical Program for Foslevodopa/Foscarbidopa Pavnit Kukreja, PharmD
11:45 AM - 12:45 PM EST	Abstract	5-008 - Optimizing Augmented Reality Cueing Strategies for Freezing of Gait in Parkinson Disease: Interim Results of the ELIMINATE FoG Study Brendan Baugher, OMS
11:45 AM - 12:45 PM EST	Abstract	5-009 - BCR-ABL Tyrosine Kinase Inhibitors in Parkinson's Disease and Lewy Body Dementia: A Systematic Review Marcos V. Marques, MD
11:45 AM - 12:45 PM EST	Abstract	5-010 - Real-World Effectiveness and Safety of Deutetrabenazine in Combination with Antipsychotic Drugs in Patients With Chorea Associated With Huntington Disease Nayla Chaijale
11:45 AM - 12:45 PM EST	Abstract	5-011 - Baseline Characteristics and Treatment Patterns of a Global Huntington Disease Population Stratified by Chorea Severity Nayla Chaijale
11:45 AM - 12:45 PM EST	Abstract	5-012 - Valbenazine Decreases Disease Burden in Patients with Chorea Associated with Huntington Disease: Patient-Reported Huntington Disease Health Index (HD-HI) Results From the KINECT-HD Trial Dietrich Haubenberger, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	5-013 - Therapeutic Challenges of Huntington's Disease in Guinea: Study of HD Confirmed Cases in a Country with Limited Resources Guelngar Carlos Othon, Jr., MD
11:45 AM - 12:45 PM EST	Abstract	5-014 - Chorea Associated with Lamotrigine Use: A case report, retrospective chart review, and literature summary Sofia Rael, MD
11:45 AM - 12:45 PM EST	Abstract	5-015 - A Bioequivalence Comparison at Steady State between the Newly Developed Once-Daily Extended Release Tablet Formulation and the Approved Twice-Daily Tablet Formulation of Deutetrabenazine Maria Sunzel, PhD
11:45 AM - 12:45 PM EST	Abstract	5-016 - Assessment of Dose Proportionality of Three Dose Strengths (6 mg, 12 mg and 24 mg) over the Clinical Dose Range (6-48 mg) of the Newly Developed Once-Daily Extended Release Tablet Formulation of Deutetrabenazine Maria Sunzel, PhD
11:45 AM - 12:45 PM EST	Abstract	2-001 - Association of a ≥2 point decrease of MoCA 1 year after noncardiac surgery with patient-important outcomes: a secondary analysis of the NeuroVISION cohort study Maura Marcucci, MD
11:45 AM - 12:45 PM EST	Abstract	2-002 - Transcutaneous Cervical Vagus Nerve Stimulation Enhances Second-Language Vocabulary Acquisition While Simultaneously Mitigating Fatigue and Promoting Focus Toshiya Miyatsu, PhD
11:45 AM - 12:45 PM EST	Abstract	2-003 - Selective NKCC1 Inhibitors for the Treatment of Neurodevelopmental and Neurological Disorders with Defective NKCC1/KCC2 expression-ratio Annalisa Savardi, PhD
11:45 AM - 12:45 PM EST	Abstract	2-004 - Higher Initial Platelet Procoagulant Potential is Associated with Lower Cognitive Scores at 14 Months after COVID-19 Claire E. Delpirou Nouh, MD
11:45 AM - 12:45 PM EST	Abstract	2-005 - A Novel Mutation in PDGFRB in a Patient with Primary Familial Brain Calcification: Case Report Jamal Al Ali, MD
11:45 AM - 12:45 PM EST	Abstract	2-006 - Proximity to Green and Blue Spaces and Serious Psychological Distress in Urban-Dwelling Older Adults: Analysis of Washington State BRFSS data Adithya Vegaraju
11:45 AM - 12:45 PM EST	Abstract	2-007 - Description of cognitive and imaging function in a cohort of COVID-19 survivors in a tertiary hospital in Mexico City. Monica Saray R. Rodríguez, Sr., MD
11:45 AM - 12:45 PM EST	Abstract	2-008 - Neuropsychiatric Presentations in Late-onset Inborn Errors of the Metabolism: A Systematic Review of the Literature Mattia Rosso, MD
11:45 AM - 12:45 PM EST	Abstract	2-009 - Functional Pseudo-Stroke Presentations in the Emergency Department at a Comprehensive Stroke Center; a 6-year Retrospective Chart Review Mohammad A. Shahab, MD, MBBS
11:45 AM - 12:45 PM EST	Abstract	11-001 - Peripheral T-Cell Lymphoma Manifesting as Multifocal Central Nervous System Disease with Prominent Spinal Cord Involvement Eesha Singh, MD
11:45 AM - 12:45 PM EST	Abstract	11-002 - Treatment of Central Nervous System Post-Transplant Lymphoproliferative Disorder in Immunocompromised Patients with Pancreas Transplant– Between the Rock and a Hard Place Maira I. Haque
11:45 AM - 12:45 PM EST	Abstract	11-003 - Cranial Neurolymphomatosis: An Analysis of Seven Cases Abigail S. Bose, MD
11:45 AM - 12:45 PM EST	Abstract	11-004 - Prevalence of Insomnia and Associated Factors Among Medical Students Who Recovered From Acute COVID-19 Infection Linker E. Viñan Paucar, Sr.
11:45 AM - 12:45 PM EST	Abstract	11-005 - A longitudinal study identifies progressive alterations in brain white matter microstructure and networks in male adults with obstructive sleep apnea and their recovery after sleep surgery Hea Ree Park
11:45 AM - 12:45 PM EST	Abstract	11-006 - Characteristics and Disease Burden of Patients With Idiopathic Hypersomnia With and Without Long Sleep Time: The Real-World Idiopathic Hypersomnia Outcomes Study (ARISE) Wayne Macfadden, MD, PT

Faculty Disclosures
Cisse Amara	No disclosure on file
Pavnit Kukreja, PharmD	Dr. Kukreja has received personal compensation for serving as an employee of AbbVie. Dr. Kukreja has stock in AbbVie.
	No disclosure on file
Sarah Elsea	The institution of Sarah Elsea has received research support from NIH. The institution of Sarah Elsea has received research support from Speragen, Inc. The institution of Sarah Elsea has received research support from PTC Therapeutics, Inc. The institution of Sarah Elsea has received research support from PRISMS, Inc. The institution of Sarah Elsea has received research support from Warren Alpert Foundation. Sarah Elsea has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH. Sarah Elsea has received personal compensation in the range of $0-$499 for serving as a Reviewer with CDMRP-DOD.
Sedat Gul, MD	Dr. Gul has nothing to disclose.
Anjali Murthy	Miss Murthy has nothing to disclose.
Manny Villar	Mr. Villar has nothing to disclose.
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with ��ɫ��. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing ��ɫ��, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Aatif M. Husain, MD	Dr. Husain has received personal compensation in the range of $0-$499 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for The Methodist Hospital. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedIQ. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Pharmaceuticals. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Husain has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Husain has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure. Dr. Husain has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceutical. The institution of Dr. Husain has received research support from Marinus Pharmaecuticals. The institution of Dr. Husain has received research support from PranaQ. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with American Clinical Neurophysiology Society. Dr. Husain has a non-compensated relationship as a Vice Chair of CNP MOC committee with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Sean J. Pittock, MD, FAAN	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Elia Sechi, MD	Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Negin Badihian, MD	Dr. Badihian has nothing to disclose.
Jennifer L. Orthmann Murphy, MD, PhD	Dr. Orthmann Murphy has received personal compensation in the range of $0-$499 for serving as a Consultant for Vigil Neuroscience. Dr. Orthmann Murphy has received personal compensation in the range of $0-$499 for serving as a Consultant for NovoGlia. The institution of Dr. Orthmann Murphy has received research support from Vigil Neurosciences. The institution of Dr. Orthmann Murphy has received research support from National MS Society. The institution of Dr. Orthmann Murphy has received research support from Fishman Family Foundation. The institution of Dr. Orthmann Murphy has received research support from Global Leukodystrophy Initiative Clinical Trial Network. The institution of Dr. Orthmann Murphy has received research support from NINDS. The institution of Dr. Orthmann Murphy has received research support from Montague Investigator Award. Dr. Orthmann Murphy has received personal compensation in the range of $500-$4,999 for serving as a Developing CME content on Neurogenetics with American Neurological Association. Dr. Orthmann Murphy has received personal compensation in the range of $500-$4,999 for serving as a Faculty, Honoraria with CMSC.
Sunjeet Brar	Miss Brar has nothing to disclose.
Barbara A. Dworetzky, MD, FAAN	Dr. Dworetzky has received publishing royalties from a publication relating to health care.
Catherine Hassett, MD	Dr. Hassett has nothing to disclose.
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.
Patrick Landazuri, MD, FAAN	Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropace. Dr. Landazuri has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Federal Public Defender - District of Kansas. Dr. Landazuri has received publishing royalties from a publication relating to health care.
Fernando D. Testai, MD, PhD, FAAN	Dr. Testai has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Testai has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Livingston, Barger, Brandt & Schroeder, L.L.P.. Dr. Testai has received publishing royalties from a publication relating to health care.
Eva M. Kesenheimer, MD	Dr. Kesenheimer has nothing to disclose.
Lekshmi Peringassery Sateesh, MD	Dr. Peringassery Sateesh has nothing to disclose.
Ye V. Liang, MD	Dr. Liang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Parth P. Parikh	Mr. Parikh has nothing to disclose.
Leslie Guthery	Leslie Guthery has nothing to disclose.
Abigail S. Bose, MD	Dr. Bose has nothing to disclose.
Dara V. Albert, DO, FAAN	Dr. Albert has nothing to disclose.
Bruce A. Cree, MD, PhD, MAS, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Smathorn Thakolwiboon, MD	Dr. Thakolwiboon has nothing to disclose.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Kazim Jaffry	Mr. Jaffry has nothing to disclose.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Nancy J. Newman, MD, FAAN	Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phelcom. The institution of Dr. Newman has received research support from GenSight. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care.
Liliana A. Ramirez-Gomez, MD, FAAN	The institution of Dr. Ramirez-Gomez has received research support from NIA-NIH.
Joseph C. Masdeu, MD, PhD, FAAN	Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
Gianmarco Abbadessa, MD	Dr. Abbadessa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Aline F. Dias, MD, Other	Miss Dias has received research support from CAPES. Miss Dias has received research support from FAPESP.
Maria Janina Wendebourg, MD	Dr. Wendebourg has nothing to disclose.
Carol Swetlik, MD	An immediate family member of Dr. Swetlik has received personal compensation for serving as an employee of Pfizer. Dr. Swetlik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Swetlik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Victor Lami, MD	Dr. Eslami has nothing to disclose.
Bernard Brais, MD	Dr. Brais has nothing to disclose.
Jay B. Lusk	Mr. Lusk has received research support from American Heart Association.
Michael M. Gezalian, MD	Dr. Gezalian has nothing to disclose.
Helen Trenz	Helen Trenz has nothing to disclose.
Valerie Biousse, MD	Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Topcon. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care.
Roy E. Strowd III, MD, FAAN	Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Kelsey M. Smith, MD	The institution of Dr. Smith has received research support from CURE Epilepsy. The institution of Dr. Smith has received research support from UCB Pharmaceuticals.
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Salvador Cruz-Flores, MD, FAAN	The institution of Dr. Cruz-Flores has received research support from University of Texas System.
Adrian I. Espiritu, MD	Dr. Espiritu has nothing to disclose.
Amy Kunchok, MBBS	Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology:Open Access Journal .
Catriona Reddin, MD	Dr. Reddin has received research support from Irish Clinical Academic Training (ICAT) Programme, the Wellcome Trust and the Health Research Board (grant number 203930/B/16/Z).
Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN	Dr. De Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurology Academy. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. De Luca has received research support from NIHR, BRC (Oxford). The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). The institution of Dr. De Luca has received research support from UK MS Society. The institution of Dr. De Luca has received research support from Oxford-Quinnipiac Partnership. The institution of Dr. De Luca has received research support from US Department of Defense. The institution of Dr. De Luca has received research support from Wellcome ISSF (Oxford). The institution of Dr. De Luca has received research support from Bristol Myers Squibb. The institution of Dr. De Luca has received research support from University of Oxford (John Fell Fund). The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). Dr. De Luca has a non-compensated relationship as a Editorial board member with MS Journal that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Vice-Chair of Grant Review Panel with UK MS Society that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Steering Group member with MS Academy that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Board of Directors with SEQUINS that is relevant to AAN interests or activities.
Jeffrey Gluckstein, MD	Dr. Gluckstein has nothing to disclose.
Jordi Bruna	Jordi Bruna has nothing to disclose.
Patrick Furey	No disclosure on file
Henrik Toft Soerensen	No disclosure on file
Claire E. Delpirou Nouh, MD	The institution of Dr. Delpirou Nouh has received research support from Oklahomas Nathan Shock Center. Dr. Delpirou Nouh has a non-compensated relationship as a Volunteer/Board member with Oklahoma Alzheimer Association that is relevant to AAN interests or activities.
Michael Mbagwu	No disclosure on file
Elise Drouin, PhD	Dr. Drouin has received personal compensation for serving as an employee of EMD Serono. Dr. Drouin has stock in Agenus.
Logan D. Schneider, MD	Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care.
Heather Moss, MD, PhD, FAAN	Dr. Moss has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Verana Health. Dr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms. The institution of Dr. Moss has received research support from NIH. The institution of Dr. Moss has received research support from Research to Prevent Blindness. Dr. Moss has received intellectual property interests from a discovery or technology relating to health care. Dr. Moss has received personal compensation in the range of $0-$499 for serving as a grant review panel with National Institutes of Health. Dr. Moss has a non-compensated relationship as a Board of Directors with North American Neuro-ophthalmology Society that is relevant to AAN interests or activities.
Srikanth Muppidi, MD, FAAN	Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Kathleen B. Digre, MD, FAAN	Dr. Digre has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Headache Society. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuro-ophthalmology. The institution of Dr. Digre has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Utah Womens Health Review. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received intellectual property interests from a discovery or technology relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care. Dr. Digre has received publishing royalties from a publication relating to health care.
Tracey A. Milligan, MD, FAAN	Dr. Milligan has received publishing royalties from a publication relating to health care.
Sasha Alick-Lindstrom, MD, MPH FACNS, FAES, FAAN	Dr. Alick-Lindstrom has nothing to disclose.
Nihal Satyadev, MD, MPH	Dr. Satyadev has nothing to disclose.
Dominic L. Julian	Mr. Julian has nothing to disclose.
Tracey Cho, MD, FAAN	Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of an immediate family member of Dr. Cho has received research support from NIH. Dr. Cho has received publishing royalties from a publication relating to health care.
Mary A. O'Neal, MD, FAAN	Dr. O'Neal has received personal compensation for serving as an employee of Best Doctors. Dr. O'Neal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Crico malpractice company. Dr. O'Neal has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Crico malpractice company. Dr. O'Neal has received publishing royalties from a publication relating to health care.
Gaston Baslet, MD	Dr. Baslet has received publishing royalties from a publication relating to health care. Dr. Baslet has a non-compensated relationship as a Professional Board Member with Epilepsy Alliance America that is relevant to AAN interests or activities.
Maryam Oskoui, MD, FAAN	Dr. Oskoui has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for the Association des Neurologues du Quebec. The institution of Dr. Oskoui has received research support from Hoffmann-La Roche Ltd. The institution of Dr. Oskoui has received research support from Muscular Dystrophy Canada. The institution of Dr. Oskoui has received research support from Canadian Institutes of Health Research. The institution of Dr. Oskoui has received research support from Santhera. The institution of Dr. Oskoui has received research support from Novartis. The institution of Dr. Oskoui has received research support from Fonds de Recherche du Québec. Dr. Oskoui has a non-compensated relationship as a Member of the Medical and Scientific Advisory Committee with Muscular Dystrophy Canada that is relevant to AAN interests or activities.
Brigitte Reina, MD	Dr. Reina has nothing to disclose.
Pninit Litman, PhD	Dr. Litman has received personal compensation for serving as an employee of PHARMA 2B.
Saad Hasan, MD	Dr. Hasan has nothing to disclose.
Sandeep S. Rana, MD, FAAN	Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSI. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmawrite. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Michael Haboubi, DO	Dr. Haboubi has nothing to disclose.
Ona Wu	The institution of Ona Wu has received research support from NIH. Ona Wu has received intellectual property interests from a discovery or technology relating to health care. Ona Wu has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH.
Calin I. Prodan, MD	The institution of Dr. Prodan has received research support from US Department of Veterans Affairs (Merit award CX000340).
Walid Bouthour, MD	Dr. Bouthour has nothing to disclose.
Neill R. Graff-Radford, MD, FAAN	The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Nora Vanegas-Arroyave, MD	The institution of Dr. Vanegas-Arroyave has received research support from National Institutes of Health. The institution of Dr. Vanegas-Arroyave has received research support from MJFF.
David L. Perez, MD, FAAN	Dr. Perez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley: Brain and Behavior. Dr. Perez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Psychiatric Association Publishing. The institution of Dr. Perez has received research support from NIH. The institution of Dr. Perez has received research support from Sidney R. Baer Jr. Foundation. The institution of Dr. Perez has received research support from Warren Alpert Foundation. Dr. Perez has received publishing royalties from a publication relating to health care. Dr. Perez has received publishing royalties from a publication relating to health care.
Emily In	Ms. In has nothing to disclose.
Marco Pisa, MD	Dr. Pisa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Pamela Rist, PhD	The institution of Dr. Rist has received research support from National Institutes of Health. The institution of Dr. Rist has received research support from Brigham and Women's Hospital. The institution of Dr. Rist has received research support from American Heart Association. The institution of Dr. Rist has received research support from Mars Edge.
Juliane Chainakul, APRN-CNS	Juliane Chainakul has nothing to disclose.
Ikjae Lee, MD	Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from Spastic Paraplegia Foundation.
Thanos Tsaktanis, MD	Dr. Tsaktanis has nothing to disclose.
Timothy J. Turner	Timothy J. Turner has received personal compensation for serving as an employee of Sanofi. Timothy J. Turner has stock in Sanofi. Timothy J. Turner has received intellectual property interests from a discovery or technology relating to health care.
Natalia Palacios, PhD	The institution of Dr. Palacios has received research support from Eisai, Inc. The institution of Dr. Palacios has received research support from NIH. The institution of Dr. Palacios has received research support from Department of Veterans Affairs. Dr. Palacios has a non-compensated relationship as a Grant Reviewer with National Institutes of Health that is relevant to AAN interests or activities. Dr. Palacios has a non-compensated relationship as a Associate Editor with Journal of Alzheimer's Disease that is relevant to AAN interests or activities. Dr. Palacios has a non-compensated relationship as a Researcher with Department of Veterans Affairs that is relevant to AAN interests or activities.
Lixin Zhou	Lixin Zhou has nothing to disclose.
Harry Zobel, Jr., DO	Dr. Zobel has nothing to disclose.
Rafael D. Borges	Mr. Borges has nothing to disclose.
Rasha Mosleh	No disclosure on file
Anna Volski, MD	Dr. Volski has nothing to disclose.
Bahadar S. Srichawla, DO, MS	Dr. Srichawla has nothing to disclose.
Saud Sadiq, BS, FAAN	Ms. Brewi has nothing to disclose.
Margaret Esiri	Margaret Esiri has stock in Cytox Group.
Federico J. Rodriguez-Porcel, MD, FAAN	Dr. Rodriguez-Porcel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioVie. Dr. Rodriguez-Porcel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WCG. Dr. Rodriguez-Porcel has received research support from NIH. Dr. Rodriguez-Porcel has received publishing royalties from a publication relating to health care.
Nan Zhang	Nan Zhang has nothing to disclose.
Emer McGrath, MB, BCh, PhD	Dr. McGrath has nothing to disclose.
Martin Berghoff, MD, FAAN	Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MerckSerono. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb.
Chao Xu	Chao Xu has nothing to disclose.
Cristina S. Ivan, MD	An immediate family member of Dr. Ivan has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Cellular and Molecular Medicine. An immediate family member of Dr. Ivan has received intellectual property interests from a discovery or technology relating to health care.
Yuehui Hong	Ms. Hong has nothing to disclose.
Olga Klepitskaya, MD, FAAN	Dr. Klepitskaya has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Klepitskaya has or had stock in Neurocrine Biosciences.
Jiping Zhou, MD, MPH	Dr. Zhou has nothing to disclose.
Isabelle Hunt, MD	Dr. Hunt has nothing to disclose.
Sylvain Rheims	No disclosure on file
Janice M. Rivera, MD	Dr. Rivera has nothing to disclose.
Eleanor Mathews	Eleanor Mathews has nothing to disclose.
Lauren Kim Sing, MD	Mrs. Kim Sing has nothing to disclose.
Sudhindra Vooturi, PT	Dr. Vooturi has nothing to disclose.
Luis Bejar, MD	Dr. Bejar has nothing to disclose.
Mathias Linnerbauer	Mr. Linnerbauer has nothing to disclose.
Galina Gheihman, MD	Dr. Gheihman has nothing to disclose.
Roberto Gomez, MD	Dr. Gomez has nothing to disclose.
Navid Manouchehri, MD	Navid Manouchehri has nothing to disclose.
Roxana M. Dragomir, MD	Dr. Dragomir has nothing to disclose.
Hal Blumenfeld, MD, PhD	Dr. Blumenfeld has nothing to disclose.
Michael Sinnreich, MD, PhD	Prof. Sinnreich has nothing to disclose.
Daniel O. Claassen, MD, FAAN	Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics . Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI.
Katherine M. Clifford, MD	Dr. Clifford has nothing to disclose.
Yi-Cheng Zhu, MD, PhD	Dr. Zhu has nothing to disclose.
Guelngar Carlos Othon, Jr., MD	Guelngar Carlos Othon has nothing to disclose.
Jamal Al Ali, MD	Dr. Al Ali has nothing to disclose.
Pierre-Francois Pradat, PhD	No disclosure on file
Krzysztof Smigorski	No disclosure on file
Bakri Elsheikh, MD, FAAN	Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex . The institution of Dr. Elsheikh has received research support from Biogen. The institution of Dr. Elsheikh has received research support from Cure SMA.
William D. Arnold, MD	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Barbara Nuesslein-Hildesheim, PhD	Dr. Nuesslein-Hildesheim has received personal compensation for serving as an employee of Novartis Pharma AG. Dr. Nuesslein-Hildesheim has stock in Novartis Pharma AG.
Dimitrios C. Ladakis, MD	Dr. Ladakis has nothing to disclose.
Brendan Baugher, OMS	Mr. Baugher has nothing to disclose.
Hiroshi Mitsumoto, MD, FAAN	Dr. Mitsumoto has nothing to disclose.
Toluwalase O. Tofade, MBBS	Dr. Tofade has nothing to disclose.
Evelyn Lazar, MD	Dr. Lazar has nothing to disclose.
Anna Blazier, PhD	Dr. Blazier has received personal compensation for serving as an employee of Sanofi.
Giovanni G. Berton	The institution of Mr. Berton has received research support from CRUI-CARE Agreement.
James F. Castellano, MD, PhD	Dr. Castellano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuro One medical technologies. The institution of Dr. Castellano has received research support from NIH. The institution of Dr. Castellano has received research support from University of Pittsburgh.
Mary Curry, ND	Mary Curry has received personal compensation for serving as an employee of Cure SMA.
Will McKeen, MD	Dr. McKeen has nothing to disclose.
Jill Jarecki, Other	Dr. Jarecki has received personal compensation for serving as an employee of Cure SMA. Dr. Jarecki has received personal compensation for serving as an employee of BioMarin. Dr. Jarecki has stock in BioMarin.
Katrina Paumier, PhD	Dr. Paumier has nothing to disclose.
Robert J. Marquardt, DO	Dr. Marquardt has nothing to disclose.
Richard L. Yates	No disclosure on file
Caroline Brethenoux	No disclosure on file
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Nathalie Kertesz, PhD	Dr. Kertesz has received personal compensation for serving as an employee of Scholar Rock Inc..
Katherine A. Julian	Miss Julian has nothing to disclose.
Sanjay Mittal, MD	Dr. Mittal has nothing to disclose.
Stephen D. Avila, MD, MBS	Dr. Avila has nothing to disclose.
Natascha Cardoso Da Fonseca, MD, PhD	Dr. Cardoso Da Fonseca has nothing to disclose.
Daniel Mafla Delgado, Sr., MD	Dr. Mafla Delgado has nothing to disclose.
Rajesh Pahwa, MD, FAAN	Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB. The institution of Dr. Pahwa has received research support from Ono. The institution of Dr. Pahwa has received research support from Intra-cellular Therapies. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Michael J Fox Foundation . The institution of Dr. Pahwa has received research support from Neuron 23. The institution of Dr. Pahwa has received research support from Roche.
Richard Carozza, MD	Dr. Carozza has nothing to disclose.
Nicola Pavese, MD	Dr. Pavese has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Pavese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Pavese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Pavese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. The institution of Dr. Pavese has received research support from Multiple System Atrophy Trust. The institution of Dr. Pavese has received research support from Parkinson's UK. The institution of Dr. Pavese has received research support from Independent Research Fund Denmark. The institution of Dr. Pavese has received research support from European Union. The institution of Dr. Pavese has received research support from MRC.
Hemani Ticku, MD	Dr. Ticku has nothing to disclose.
Joyce A. Jimenez Zambrano, MD	Dr. Jimenez Zambrano has nothing to disclose.
Firas Kaddouh, MD	Dr. Kaddouh has nothing to disclose.
Cheryl Fitzer-Attas, PhD	Dr. Fitzer-Attas has received personal compensation for serving as an employee of Sage Therapeutics. The institution of Dr. Fitzer-Attas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pharma Two B. The institution of Dr. Fitzer-Attas has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Golden Heart Flower. The institution of Dr. Fitzer-Attas has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Sage Therapeutics. Dr. Fitzer-Attas has stock in Golden Heart Flower. Dr. Fitzer-Attas has received intellectual property interests from a discovery or technology relating to health care.
Amit Saindane	No disclosure on file
Tarek Zakaria, MD	Dr. Zakaria has nothing to disclose.
Satabdi Chakrabarti Pulakanti, DO	Dr. Chakrabarti Pulakanti has nothing to disclose.
Judith E. Warner, MD	Dr. Warner has received intellectual property interests from a discovery or technology relating to health care.
Orna O'Toole, MB, BCh, BAO MD	Dr. O'Toole has nothing to disclose.
Natalia S. Rost, MD, MPH, FAAN, FAHA	Dr. Rost has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for ��ɫ��. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
Joshua M. Shulman, MD, PhD, FAAN	Dr. Shulman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Helis Medical Foudation. The institution of Dr. Shulman has received research support from National Institutes of Health.
Philip W. Tipton, MD	Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc.
Gary W. Clauser, MD	Dr. Clauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bigoen . The institution of Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Clauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech . Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genzyme. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Clauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartid.
Ryan Kaya, PT	Mr. Kaya has nothing to disclose.
Roberta La Piana	Roberta La Piana has received research support from Canadian Institute Health Research. Roberta La Piana has received research support from Ataxia Canada. Roberta La Piana has received research support from Spastic Paraplegia Foundation. Roberta La Piana has received research support from Fonds de Recherche en Santé du Quebec. Roberta La Piana has received research support from Roche Canada. Roberta La Piana has received research support from ARSACS Foundation.
James A. Mastrianni, MD, PhD	Dr. Mastrianni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Caremark. Dr. Mastrianni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Mastrianni has received research support from Brain Research Foundation.
Jaime Raymond	Jaime Raymond has nothing to disclose.
Mustafa Jaffry	Mr. Jaffry has nothing to disclose.
Afsaneh Talai, MD	Dr. Talai has nothing to disclose.
Valentina Damato, MD, PhD	Dr. Damato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Damato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Damato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma.
Fernando Cendes, MD, PhD, FAAN	Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Juho Joutsa	No disclosure on file
Cory P. Hackmyer, DO	Dr. Hackmyer has nothing to disclose.
Amanda Cyntia Lima Fonseca Rodrigues	Ms. Rodrigues has nothing to disclose.
Leticia F. Ribeiro	Ms. Ribeiro has nothing to disclose.
Marie Beaudin, MD	Dr. Beaudin has nothing to disclose.
Jun Ni	Jun Ni has nothing to disclose.
Angelo Antonini, MD	Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Antonini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for THERAVANCE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ZAMBON. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BOEHRINGER.
José Andrés A. Jara Escobar	Mr. Jara Escobar has nothing to disclose.
Amit Bar-Or, MD, FRCPC	Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Kassi Kronfeld, MD	Dr. Kronfeld has nothing to disclose.
David Kreitzman, MD	Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Kreitzman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cereval. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Acadia Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Kreitzman has received research support from pharma 2b. Dr. Kreitzman has received research support from Neurocrine. Dr. Kreitzman has received research support from Addex. Dr. Kreitzman has received research support from Amneal.
Erin Furr-Stimming, MD, FAAN	Dr. Furr-Stimming has received personal compensation for serving as an employee of Help4HD International. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedPage. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atalanta Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SkyHawk Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atalanta Therapeutics. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine Bioscienes. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from Sage Therapeutics. The institution of Dr. Furr-Stimming has received research support from HDSA. The institution of Dr. Furr-Stimming has received research support from Prilennia. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has a non-compensated relationship as a Committee member with AAN UES Committee that is relevant to AAN interests or activities.
Anuja R. Patil, MD, DM	Dr. Patil has nothing to disclose.
Chi-Ying (Roy) Lin, MD, FAAN	Dr. Lin has received research support from Texas Alzheimer's Research and Care Consortium (TARCC). Dr. Lin has received research support from CurePSP. Dr. Lin has received research support from Mike Hogg Fund. Dr. Lin has received research support from The Michael J. Fox Foundation Parkinson's Progression Markers Initiative (PPMI). Dr. Lin has a non-compensated relationship as a Secretary with Broadway for Ataxia Foundation (a 501 (c) (3) non-profit organization) that is relevant to AAN interests or activities.
Mohammad R. Ghani, MD	Dr. Ghani has nothing to disclose.
Brian Mac Grory, MB BCh BAO	An immediate family member of Dr. Mac Grory has received personal compensation for serving as an employee of Sanofi. Dr. Mac Grory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Mac Grory has received research support from National Institutes of Health. The institution of Dr. Mac Grory has received research support from American Heart Association.
Bruno Bergmans	Bruno Bergmans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Bruno Bergmans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Inc.. Bruno Bergmans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz GmbH. Bruno Bergmans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Bruno Bergmans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie Inc.. The institution of Bruno Bergmans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz GmbH. The institution of Bruno Bergmans has received research support from Abbvie Inc.. The institution of Bruno Bergmans has received research support from Merz GmbH. Bruno Bergmans has a non-compensated relationship as a MDS Young Members Group Steering Committee Vice-Chair with International Parkinson and Movement DIsorder Society (MDS) that is relevant to AAN interests or activities.
Yuka Martens	No disclosure on file
Negar Moheb, MD	Dr. Moheb has nothing to disclose.
Sukhmani Sandhu, MD	Dr. Sandhu has nothing to disclose.
Melinda Power, PhD	Melinda Power, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Hea Ree Park	Hea Ree Park has nothing to disclose.
Oleg Y. Chernyshev, MD, PhD, FAAN	Dr. Chernyshev has nothing to disclose.
Bradley J. Katz, MD, PhD	Bradley J. Katz, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for axon optics, LLC. Bradley J. Katz, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for self employed. Bradley J. Katz, MD, PhD has received stock or an ownership interest from Pfizer. Bradley J. Katz, MD, PhD has received intellectual property interests from a discovery or technology relating to health care.
Deborah M. Green-LaRoche, MD	The institution of Dr. Green-LaRoche has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Clinical Trials. Dr. Green-LaRoche has received publishing royalties from a publication relating to health care.
Wendy E. Kaye, PhD	Dr. Kaye has received personal compensation for serving as an employee of McKing Consulting Corporation. Dr. Kaye has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Association for the Protection of Human Research Participants.
Bernadeth Lyn C. Piamonte, MD	Dr. Piamonte has nothing to disclose.
Sam H. Horng, MD, PhD	The institution of Dr. Horng has received research support from National Institutes of Health . The institution of Dr. Horng has received research support from Jayne and Harvey Beker Foundation .
Roland Dominic Jamora	Roland Dominic Jamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for torrent. Roland Dominic Jamora has received research support from CCXDP.
Jordan L. Clay, MD	Dr. Clay has nothing to disclose.
Octavio Carranza-Renteria, MD	Dr. Carranza-Renteria has nothing to disclose.
Angelia Kirkpatrick	Angelia Kirkpatrick has nothing to disclose.
Yookyeong Baek, MD	Dr. Baek has nothing to disclose.
Michael D. Geschwind, MD, PhD, FAAN	Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Elizabeth A. Coon, MD, FAAN	Dr. Coon has received publishing royalties from a publication relating to health care. Dr. Coon has a non-compensated relationship as a Non-Voting Member of the Board of Directors with UCNS that is relevant to AAN interests or activities.
Jaime Imitola, MD, FAAN	The institution of Dr. Imitola has received research support from Genentech. Dr. Imitola has a non-compensated relationship as a Board Member with National MS Society that is relevant to AAN interests or activities. Dr. Imitola has a non-compensated relationship as a Committee Member with International Society for Stem Cell Research that is relevant to AAN interests or activities.
Christopher T. Doughty, MD	Dr. Doughty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurometrix. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Doughty has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Doughty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TD Securities. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Adler¦Cohen¦Harvey¦Wakeman¦Guekguezian, LLP. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gidley, Sarli & Marusak, LLP. Dr. Doughty has received research support from NINDS/NeuroNEXT. Dr. Doughty has received research support from AstraZeneca. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as a Grant Advisory Board Member with Dysimmune Diseases Foundation. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as a CME Lecturer with Oakstone Publishing.
Naila Kausar, MD	Dr. Kausar has nothing to disclose.
James Hiana, MD	Dr. Hiana has nothing to disclose.
Sarah Harris	Sarah Harris has received personal compensation for serving as an employee of BMS. Sarah Harris has stock in BMS.
Antonio Arauz, MD, PhD	Dr. Arauz has nothing to disclose.
Amandeep Dolla, MBBS	Dr. Dolla has nothing to disclose.
Ron J. Danziger, MD	Dr. Danziger has nothing to disclose.
Mark Hays	No disclosure on file
Eun-Yeon Joo, MD	Dr. Joo has nothing to disclose.
Satinderpal Singh, DO	Dr. Singh has nothing to disclose.
Chae Y. Kim, MD	Dr. Kim has nothing to disclose.
Pakinam Aboutaleb, MD	Dr. Aboutaleb has nothing to disclose.
Stacey N. Ho, MD	Dr. Ho has nothing to disclose.
Clarissa L. Yasuda, MD, PhD	Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
George Small, MD	Dr. Small has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Pietro Zara, MD	Dr. Zara has nothing to disclose.
Alan R. Hirsch, MD, FACP	Dr. Hirsch has nothing to disclose.
Aracelis Torres	No disclosure on file
Connie H. Yan, PhD, PharmD	Dr. Yan has received personal compensation for serving as an employee of AbbVie Inc. Dr. Yan has stock in AbbVie Inc.
Alex Lorenzo	No disclosure on file
Timothy Quezada, MD	Dr. Quezada has nothing to disclose.
Ellen Bubrick, MD	Dr. Bubrick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure.
Manasa Gunturu, MD	Dr. Gunturu has nothing to disclose.
Vikram Shivkumar, MD, FAAN	Dr. Shivkumar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Akhil Shivaprasad, MBBS	Dr. Shivaprasad has nothing to disclose.
Hussein Al-Khalidi	No disclosure on file
Nicolas Dupre, MD, FAAN	Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Micah Etter, MD	Dr. Etter has nothing to disclose.
A. Blake Buletko, MD	Dr. Buletko has nothing to disclose.
Andrea R. Lowden, MD	Dr. Lowden has nothing to disclose.
Sushma R. Yerram, MD	Dr. Yerram has nothing to disclose.
Muhammad I. Yousaf, MD	Dr. Yousaf has nothing to disclose.
Ning Su, MD	Dr. Su has nothing to disclose.
Alex La Croix	Mr. La Croix has received personal compensation for serving as an employee of Praxis Precision Medicines. Mr. La Croix has stock in Praxis Precision Medicines.
Dipali P. Nemade, MD	Dr. Nemade has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Gennaro Pagano, MD, PhD, FEAN, eMBA	Prof. Pagano has received personal compensation for serving as an employee of F.Hoffmann-La Roche Ltd. Prof. Pagano has stock in F.Hoffmann La Roche Ltd.
Bhavika Kakadia, DO	Dr. Kakadia has nothing to disclose.
Maja Jagodic	No disclosure on file
Joanne Stevens, BA	Ms. Stevens has stock in Jazz Pharmaceuticals.
Taimoor Hussain, MD	Dr. Hussain has nothing to disclose.
Jennifer Harris, MD	Dr. Harris has nothing to disclose.
Yuzhou Guan	No disclosure on file
Matthias Weigel, PhD	The institution of Matthias Weigel, PhD has received research support from Biogen. Matthias Weigel, PhD has received intellectual property interests from a discovery or technology relating to health care.
Annalisa Savardi, PhD	Dr. Savardi has received personal compensation for serving as an employee of Iama Therapeutics. Dr. Savardi has stock in Iama Therapeutics. The institution of Dr. Savardi has received research support from Jerome Lejeune Foundation. Dr. Savardi has received intellectual property interests from a discovery or technology relating to health care.
James Doherty, PhD	Dr. Doherty has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Doherty has received stock or an ownership interest from Sage Therapeutics.
Amy E. Bullock, PhD	Dr. Bullock has received personal compensation for serving as an employee of Sage Therapeutics, Inc. . Dr. Bullock has stock in Sage Therapeutics, Inc.
Vilakshan Alambyan, MBBS	Dr. Alambyan has stock in Teleflex. Dr. Alambyan has stock in Natera. Dr. Alambyan has stock in Labcorp. Dr. Alambyan has stock in Veracyte. Dr. Alambyan has stock in Vicarious Surgical. Dr. Alambyan has stock in Unity Biotechnology. Dr. Alambyan has stock in Scynexis. Dr. Alambyan has stock in Stryker. Dr. Alambyan has stock in Eli Lilly. Dr. Alambyan has stock in DaVita. Dr. Alambyan has stock in Invitae. Dr. Alambyan has stock in Pfizer. Dr. Alambyan has stock in Bristol-Myers Squibb. Dr. Alambyan has stock in Johnson and Johnson. Dr. Alambyan has stock in Merck. Dr. Alambyan has stock in Medtronic. Dr. Alambyan has stock in AbbVie. The institution of Dr. Alambyan has received research support from Albert Einstein Healthcare Network.
Liat Adar	Liat Adar has received personal compensation for serving as an employee of Neuroderm.
Derrick Barnagian, MD, BS	Mr. Barnagian has nothing to disclose.
Elise P. Kayson, RN	Elise Paulin Kayson, RN has nothing to disclose.
Sally V. Mathias, MD, FANA, FAES, FAAN	Dr. Mathias has or had stock in Abbvie Inc.Dr. Mathias has received personal compensation in the range of $100,000-$499,999 for serving as a neurologist with Department of Veterans Affairs (VHA).
Alonso Gutierrez Romero, MD	Dr. Gutierrez Romero has nothing to disclose.
Sabeena I. Malik, MD	Dr. Malik has nothing to disclose.
Marwa A. Elnazeir, MD	Dr. Elnazeir has nothing to disclose.
Rami Massie, MD	Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gowlingwlg. Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as a Lecturer with Pfizer. Dr. Massie has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Argenx.
Megan C. Leary, MD	Dr. Leary has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Clinical Research Institute. Dr. Leary has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Baim Clinical Research Institute. Dr. Leary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Syneos Health. Dr. Leary has received publishing royalties from a publication relating to health care.
Per Odin	Per Odin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for Britannia. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for Convatec. Per Odin has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB.
Vyanka Redenbaugh, MB BCh BAO	Dr. Redenbaugh has nothing to disclose.
Joey Hsu, MD	The institution of Mr. Hsu has received research support from Walter L. Copeland Fund of the Pittsburgh Foundation.
Eesha Singh, MD	Dr. Singh has nothing to disclose.
Tinatin Chabrashvili, MD	Dr. Chabrashvili has nothing to disclose.
Bruno Cenni, PhD	No disclosure on file
Tina Sood	Ms. Sood has nothing to disclose.
Lucia Moiola, MD, PhD	Dr. Moiola has nothing to disclose.
Liying Cui, PhD	No disclosure on file
Scott Grossman, MD	Dr. Grossman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acuta Pharmaceuticals.
Ali G. Hamedani, MD, MHS	Dr. Hamedani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Hamedani has received personal compensation in the range of $0-$499 for serving as a Consultant for LoQus23. The institution of Dr. Hamedani has received research support from NIH. The institution of Dr. Hamedani has received research support from Biogen. The institution of Dr. Hamedani has received research support from Biohaven.
Anam K. Shaikh	Miss Shaikh has nothing to disclose.
Hubert H. Fernandez, MD, FAAN	Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Roger Barker, PhD	Roger Barker, PhD has nothing to disclose.
Sheetal Shroff, MD	Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. Dr. Shroff has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Mohamed El Refaey, MBBCH	Dr. El Refaey has nothing to disclose.
Wayne Macfadden, MD, PT	Dr. Macfadden has received personal compensation for serving as an employee of Jazz pharma. Dr. Macfadden has stock in Jazz pharma.
Talita D'Aguiar Rosa, MD	Dr. D'Aguiar Rosa has nothing to disclose.
Shan Siddiqi, MD	Dr. Siddiqi has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Magnus Medical. Dr. Siddiqi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brainsway Ltd. Dr. Siddiqi has stock in Brainsway Ltd. Dr. Siddiqi has stock in Magnus Medical. Dr. Siddiqi has received intellectual property interests from a discovery or technology relating to health care.
Francisco J. Quintana, PhD	Dr. Quintana has nothing to disclose.
Chad R. Heatwole, MD, FAAN	Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Virginia Commonwealth University. Dr. Heatwole has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Legal Med. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Heatwole has received personal compensation in the range of $0-$499 for serving as a Consultant for Iris. Dr. Heatwole has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Recursion. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Biosciences. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for New York Central Mutual. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Penn Prop and Gas. The institution of Dr. Heatwole has received research support from Department of Defense. The institution of Dr. Heatwole has received research support from Novartis. The institution of Dr. Heatwole has received research support from MJFF. The institution of Dr. Heatwole has received research support from FARA. The institution of Dr. Heatwole has received research support from NIH. The institution of Dr. Heatwole has received research support from University of Miami. The institution of Dr. Heatwole has received research support from MDA. Dr. Heatwole has received intellectual property interests from a discovery or technology relating to health care.
Joseph F. Rizzo III, MD	An immediate family member of Dr. Rizzo has received personal compensation for serving as an employee of LIfeBiosciences. Dr. Rizzo has received intellectual property interests from a discovery or technology relating to health care. Dr. Rizzo has received intellectual property interests from a discovery or technology relating to health care.
Israel F. Rosero Basurto	Mr. Rosero Basurto has nothing to disclose.
Muhammad W. Anjum, MD	Dr. Anjum has nothing to disclose.
Shailee S. Shah, MD	Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Shah has received publishing royalties from a publication relating to health care.
Sita J. Sattaluri	Dr. Sattaluri has nothing to disclose.
Jill M. Farmer, DO, MPH	Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Supernus. Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acadia. Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Farmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. Dr. Farmer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Live. The institution of Dr. Farmer has received research support from Parkinson's Foundation.
Kranthi K. Mandava	Mr. Mandava has nothing to disclose.
Corey A. McGraw, MD	The institution of Dr. McGraw has received research support from Novartis. The institution of Dr. McGraw has received research support from F. Hoffmann - La Roche. The institution of Dr. McGraw has received research support from Genentech. The institution of Dr. McGraw has received research support from Neurona Therapeutics. The institution of Dr. McGraw has received research support from Instituto Grifols, S.A..
Jonathan M. Towne	The institution of Mr. Towne has received research support from the American Epilepsy Society (Predoctoral Research Fellowship) and the National Institutes of Health (F31NS131025, T32TR004545, T32GM113896).
George Dale	George Dale has nothing to disclose.
Belen Pascual, PhD	The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH.
Ming Yao	Ming Yao has nothing to disclose.
Vinothkumar Rajendran	Mr. Rajendran has nothing to disclose.
Linker E. Viñan Paucar, Sr.	Mr. Viñan Paucar has nothing to disclose.
Erik V. Burton, MD	Dr. Burton has nothing to disclose.
Maura Marcucci, MD	Dr. Marcucci has nothing to disclose.
Erafat Rehim, MD	Dr. Rehim has nothing to disclose.
Vinay Lakki, MBBS	Dr. Lakki has nothing to disclose.
Anvesh Balabhadra, MBBS	Dr. Balabhadra has nothing to disclose.
Jaysingh Singh, MD	Dr. Singh has nothing to disclose.
Nina Long, DO	Dr. Long has nothing to disclose.
Theodore Larson	Theodore Larson has nothing to disclose.
Amy Place	Amy Place has received personal compensation for serving as an employee of Scholar Rock. Amy Place has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Tegus. Amy Place has stock in Scholar Rock.
Ram Mohan R. Sankaraneni, MD, FANA, FAES, FAAN	Dr. Sankaraneni has nothing to disclose.
Nicole R. Cardoso, MS	Miss Cardoso has nothing to disclose.
Mary K. Schroth, MD	Dr. Schroth has received personal compensation for serving as an employee of Cure SMA. The institution of Dr. Schroth has received research support from Biogen.
Raul Anwar Garcia Santos, MD	Dr. Santos has nothing to disclose.
Rashid A. Ahmed, MD	Dr. Ahmed has nothing to disclose.
John C. Morris, MD, FAAN	Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
Douglas S. Fuller	Mr. Fuller has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Mr. Fuller has stock in Jazz Pharmaceuticals.
Toshiya Miyatsu, PhD	Dr. Miyatsu has nothing to disclose.
Karan Philip, MBBS	Dr. Philip has nothing to disclose.
Niravkumar Barot, MD	Dr. Barot has nothing to disclose.
Sam Leo, PharmD	Dr. Leo has received personal compensation for serving as an employee of Teva Pharmaceutical Industries.
Subhan Khan, MD	Dr. Khan has received personal compensation for serving as an employee of University of Kentucky.
Pavan Bhargava, MD, FAAN	The institution of Dr. Bhargava has received research support from EMD Serono. The institution of Dr. Bhargava has received research support from Amylyx pharmaceuticals. The institution of Dr. Bhargava has received research support from Genentech. The institution of Dr. Bhargava has received research support from GSK.
Lauren E. Eisenman, Other	Ms. Eisenman has received personal compensation for serving as an employee of Cure SMA.
Tanmay Mehta	Mr. Mehta has nothing to disclose.
Ying Tan, MD	Dr. Tan has nothing to disclose.
Serpil Eraslan	No disclosure on file
Meagan D. Seay, DO	Dr. Seay has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various attorneys.
Steven R. Dunham, Jr., MD	Dr. Dunham has nothing to disclose.
William Drew	Mr. Drew has nothing to disclose.
James Soh, MD, PhD	Dr. Soh has nothing to disclose.
Sara Benitez, MD	Dr. Benitez has nothing to disclose.
Zarmina Mufti, MD	Dr. Mufti has nothing to disclose.
Ashley E. Anderson, MD	Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/Johnson&Johnson. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Dietrich Haubenberger, MD, FAAN	Dr. Haubenberger has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Haubenberger has stock in Neurocrine Biosciences. Dr. Haubenberger has a non-compensated relationship as a Member of the Board with American Society for Experimental Neurotherapeutics that is relevant to AAN interests or activities.
Jody Goldstein	No disclosure on file
Jay L. Alberts, PhD	Dr. Alberts has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceraxis. Dr. Alberts has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceraxis. The institution of Dr. Alberts has received research support from NIH. The institution of Dr. Alberts has received research support from Department of Defense. The institution of Dr. Alberts has received research support from Michael J. Fox Foundation. Dr. Alberts has received intellectual property interests from a discovery or technology relating to health care. Dr. Alberts has received personal compensation in the range of $500-$4,999 for serving as a Member, Health and Wellness Council with Peloton Interactive.
Kenneth L. Marek, MD	Dr. Marek has received personal compensation for serving as an employee of IND. Dr. Marek has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for invicro. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for takeda. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Koneksa. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xingimaging. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuron23. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Marek has received research support from Michael J Fox Foundation.
Ram C. Gowda, MD	Dr. Gowda has nothing to disclose.
Jeremy M. Bingen	Mr. Bingen has nothing to disclose.
Rayaz A. Malik, MBBS, PhD	Prof. Malik has nothing to disclose.
Giacomo Lus	Giacomo Lus has nothing to disclose.
Ken Baker	No disclosure on file
Elisabetta Signoriello	Elisabetta Signoriello has nothing to disclose.
Matthew Bloch, MD	Dr. Bloch has nothing to disclose.
Martina Absinta, MD	Dr. Absinta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Absinta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata Therapeutics. The institution of Dr. Absinta has received research support from International MS Alliance. The institution of Dr. Absinta has received research support from FRRB Early Career Award. The institution of Dr. Absinta has received research support from Cariplo Foundation.
Leslie D. Delfiner, MD	Dr. Delfiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Delfiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapies. Dr. Delfiner has received personal compensation in the range of $500-$4,999 for serving as a MDA Engage Event Chair and speaker with Muscular Dystrophy Association.
Gaurav Kathuria, MD	Dr. Kathuria has nothing to disclose.
Bernhard Hemmer	No disclosure on file
James K. Sheffield, MD	Dr. Sheffield has received personal compensation for serving as an employee of BMS.
Cindy Luan, MD	Dr. Luan has nothing to disclose.
Lauren R. Moo, MD, FAAN	Dr. Moo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pilltrax. An immediate family member of Dr. Moo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. Dr. Moo has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Smith Mirabella Blake. The institution of Dr. Moo has received research support from VA HSR&D. The institution of Dr. Moo has received research support from VA Office of Rural Health. Dr. Moo has received research support from NIH.
John Benalcazar	No disclosure on file
Annie E. McDermott	Ms. McDermott has nothing to disclose.
Lisa Belter	Lisa Belter has received personal compensation for serving as an employee of Cure SMA.
Marina Giovannini, MD	Ms. Giovannini has nothing to disclose.
Shahed Toossi, MD	Dr. Toossi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zoll, Inc. Dr. Toossi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various legal firms .
Laura Rabinovich-Guilatt	No disclosure on file
W. O. Tobin, PhD, MBBCh, BAO, FAAN	Dr. Tobin has received publishing royalties from a publication relating to health care.
George W. Culler IV, MD	Dr. Culler has nothing to disclose.
M. Maria Glymour, PhD	No disclosure on file
Henry Jacotin	Henry Jacotin has received personal compensation for serving as an employee of Praxis Precision Medicines. Henry Jacotin has stock in Praxis Precision Medicines. Henry Jacotin has stock in Clover Health. Henry Jacotin has stock in Certara. Henry Jacotin has stock in Takeda. Henry Jacotin has received personal compensation in the range of $500,000-$999,999 for serving as a VP Clinical Development and Pharmacovigilance with Praxis Precision Medicines.
Pratibha Surathi, MD	Dr. Surathi has nothing to disclose.
Denis Babici, MD	Dr. Babici has nothing to disclose.
Rachel Smith	Rachel Smith has nothing to disclose.
Aaron Koenig	Aaron Koenig has received personal compensation for serving as an employee of Sage Therapeutics.
Jurriaan Peters, MD	Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Peters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Peters has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for CRICO. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for UCB.
Jacqueline Pesa	Jacqueline Pesa has received personal compensation for serving as an employee of Johnson and Johnson.
Nanthaya Tisavipat, MD	Miss Tisavipat has nothing to disclose.
Mark F. Gordon, MD, FAAN	Dr. Gordon has received personal compensation for serving as an employee of Teva. Dr. Gordon has stock in Teva.
Alex C. Aw, MD	Mr. AW has nothing to disclose.
Ruham Alshiekh Nasany, MD	Dr. Alshiekh Nasany has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J&J.
Nicolas Daviaud, PhD	Nicolas Daviaud has nothing to disclose.
Rui T. Tang, MD	Mr. Tang has nothing to disclose.
Ranjithkumar Rajendran	Mr. Rajendran has nothing to disclose.
Diana M. Barratt, MD, MPH, FAAN	Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Legally Pink, LLC. Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Vlantis Law, LLC. Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Traub Lieberman. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Callahan Fusco. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Chane Socarras. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Conroy Simberg. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Crandall & Katt. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kelley Kronenberg. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Plakas Mannos. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marshall Denehey. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Pritt & Spano. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Russo Law.
Muhammad Bhatti, MD	Dr. Bhatti has nothing to disclose.
Holly Elser, MD, PhD	Dr. Elser has nothing to disclose.
Vittorio Martinelli	Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Frederic Schaper, MD, PhD	Dr. Schaper has nothing to disclose.
Sahin Avci	No disclosure on file
Paolo Solla, MD	Dr. Solla has nothing to disclose.
Nektaria Alexandri	Nektaria Alexandri has received personal compensation for serving as an employee of Merck Healthcare KGaA.
Resmi Gupta	Resmi Gupta has nothing to disclose.
Dirk Fischer	The institution of Dirk Fischer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann La Roche AG. The institution of Dirk Fischer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann La Roche AG.
Kenzie I. Keeney	Mrs. Keeney has nothing to disclose.
Niloofar Yari, MD	Dr. Yari has nothing to disclose.
Maria I. Reyes-Mantilla, MD	Dr. Reyes-Mantilla has nothing to disclose.
Jon A. Karel, MD	Dr. Karel has nothing to disclose.
Fernando Labella Alvarez, MD	Dr. Labella Alvarez has received research support from Fundación Alfonso Martín Escudero.
Amalie Chen, MD	Dr. Chen has nothing to disclose.
Katie Weeks	Mrs. Weeks has nothing to disclose.
Farah Wahbeh, MD	Ms. Wahbeh has nothing to disclose.
Mattia Rosso, MD	Dr. Rosso has nothing to disclose.
Marina K. Alvim	Dr. Alvim has nothing to disclose.
Michael Carrithers, MD, PhD	The institution of Dr. Carrithers has received research support from Biogen.
Claire Simon, DO	Dr. Simon has nothing to disclose.
Maranatha Ayodele, MD	Dr. Ayodele has nothing to disclose.
Stephanie McGovern, NP	Mrs. McGovern has nothing to disclose.
Richard J. O'Brien, MD	Dr. O'Brien has nothing to disclose.
Lan Lee	No disclosure on file
Peter Fox	No disclosure on file
Hulya Kayserili	No disclosure on file
Lucas S. Silva, MD	Dr. Silva has nothing to disclose.
Al-alya Alsabah, MD	Dr. Alsabah has nothing to disclose.
Karl E. Misulis, MD, PhD, FAAN	Dr. Misulis has received publishing royalties from a publication relating to health care.
Maryam Matloub, MD	Dr. Matloub has nothing to disclose.
Zia U. Choudhry, MD, PhD	Dr. Chaudhry has received personal compensation for serving as an employee of Johnson & Johnson. Dr. Chaudhry has received personal compensation for serving as an employee of Takeda Pharmaceuticals.
Carter A. Bell	Mr. Bell has nothing to disclose.
Joon Y. Kang, MD	Dr. Kang has nothing to disclose.
Tjalf Ziemssen, MD, FAAN	Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Federica Esposito	Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Federica Esposito has received research support from Italian MS Society. The institution of Federica Esposito has received research support from Italian Ministry of Health. The institution of Federica Esposito has received research support from ERA Net. The institution of Federica Esposito has received research support from European Commission. Federica Esposito has received intellectual property interests from a discovery or technology relating to health care.
Piraye Oflazer	No disclosure on file
Laura Sander, MD	Dr. Sander has nothing to disclose.
Hadas Friedman, Other	Mrs. Friedman has received personal compensation for serving as an employee of Pharma Two B.
Atef Kokash, DO	Dr. Kokash has nothing to disclose.
Prateek Kumar, MD	Dr. Kumar has nothing to disclose.
Yann Hyvert, PhD	Dr. Hyvert has received personal compensation for serving as an employee of The healthcare business of Merck KGaA, Darmstadt, Germany. An immediate family member of Dr. Hyvert has received personal compensation for serving as an employee of The healthcare business of Merck KGaA, Darmstadt, Germany.
Adeenah Ahmed, MD	Ms. Ahmed has nothing to disclose.
Mohammed Alwahaidy, MD	Dr. Alwahaidy has nothing to disclose.
Sheila Oren, MD, MBA	Sheila Oren, MD, MBA has received personal compensation for serving as an employee of Neuroderm. Sheila Oren, MD, MBA has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuroderm.
Michelle Anlacan	Michelle Anlacan has received personal compensation in the range of $0-$499 for serving as a Consultant for Torrent Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Medichem Philippines. Michelle Anlacan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hi Eisai Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Natrapharm Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Alzheimer's disease association of the philippines. Michelle Anlacan has received research support from Philippine Council for Health Research and Development. Michelle Anlacan has received research support from Philippine Neurological Association.
Kristina M. Kelly, PT	Dr. Kelly has nothing to disclose.
Nicholas J. Bellacicco, DO	Dr. Bellacicco has nothing to disclose.
Sara A. Finkelstein, MD	Dr. Finkelstein has nothing to disclose.
Carlos Garcia Rodriguez, MD	Dr. Garcia Rodriguez has nothing to disclose.
Mohammad A. Shahab, MD, MBBS	Dr. Shahab has nothing to disclose.
Anto Bagic, MD, PhD	Dr. Bagic has nothing to disclose.
Nayla Chaijale	Nayla Chaijale has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Ross C. Gruber, PhD	Dr. Gruber has received personal compensation for serving as an employee of Sanofi. Dr. Gruber has received stock or an ownership interest from Sanofi.
Cleo Zarina A. Reyes, MD	Dr. Reyes has nothing to disclose.
Shruthi S. Sivakumar, MBBS	Dr. Sivakumar has nothing to disclose.
Ivan Da Silva, MD	Dr. Da Silva has nothing to disclose.
Giulia Ghibellini, PhD	Dr. Ghibellini has received personal compensation for serving as an employee of Teva Pharmaceutical. Dr. Ghibellini has stock in Teva Pharmaceuticals.
Nisa Vorasoot, MD	Dr. Vorasoot has nothing to disclose.
Jose E. Cavazos, MD, PhD	Dr. Cavazos has received stock or an ownership interest from Brain Sentinel . The institution of Dr. Cavazos has received research support from NIH.
Monica Saray R. Rodríguez, Sr., MD	Dr. Rodríguez has nothing to disclose.
Marcos V. Marques, MD	Dr. Marques has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for PTC Therapeutics. Dr. Marques has received research support from Eurofarma. Dr. Marques has received research support from PTC Therapeutics. Dr. Marques has received research support from Roche.
Mark Hester, PhD	Dr. Hester has nothing to disclose.
Saniya Pervin, MD	Dr. Pervin has nothing to disclose.
Alexander L. Cohen, MD, PhD, FAAN	The institution of Dr. Cohen has received research support from NIH. The institution of Dr. Cohen has received research support from Simons Foundation.
Rachel Maddux	Rachel Maddux has nothing to disclose.
Yohannes S. Mulatu, MD	Dr. Mulatu has nothing to disclose.
Noor Mahmoud, MD	Dr. Mahmoud has nothing to disclose.
Thanh Phuong Pham Nguyen, PharmD, MBA, MSCE	The institution of Dr. Pham Nguyen has received research support from National Institute of Health. The institution of Dr. Pham Nguyen has received research support from National Institute of Health.
Sviatoslav Redko, MD	Dr. Redko has nothing to disclose.
Marc Balcer	No disclosure on file
Ajay Menon, MD	Dr. Menon has nothing to disclose.
Nora Ko, MD	Dr. Ko has nothing to disclose.
Eleni Drakou, MD	Dr. Drakou has nothing to disclose.
Angud Mehdi, MD	Dr. Mehdi has nothing to disclose.
Moon Han, PhD	Dr. Han has nothing to disclose.
Vijayakumar Javalkar, MD, MCh, FAAN	Dr. Javalkar has nothing to disclose.
Cris S. Constantinescu, MD, PhD	Dr. Constantinescu has received publishing royalties from a publication relating to health care.
Justin L. Sim, MD	Mr. Sim has nothing to disclose.
Tanish Modi, MBBS	Dr. Modi has nothing to disclose.
Cristina Granziera, MD, PhD	The institution of Prof. Granziera has received research support from Novartis. The institution of Prof. Granziera has received research support from Hoffmann La Roche. The institution of Prof. Granziera has received research support from Genzyme Sanofi. The institution of Prof. Granziera has received research support from Biogen.
Shakthi Unnithan	No disclosure on file
Laura Gutierrez Quiceno, MD	Dr. Gutierrez Quiceno has nothing to disclose.
Hesham Masoud, MD	Dr. Masoud has nothing to disclose.
Julie E. Staals, MD	Dr. Staals has nothing to disclose.
Yahya J. Abdulrahman	Mr. Abdulrahman has nothing to disclose.
Margarita Fedorova, MD	Ms. Fedorova has nothing to disclose.
Adithya Vegaraju	Mr. Vegaraju has nothing to disclose.
Katherine D. Mathews, MD, FAAN	Dr. Mathews has received personal compensation for serving as an employee of Avidity Bioscience. The institution of Dr. Mathews has received research support from NIH. The institution of Dr. Mathews has received research support from Centers for Disease Control and Prevention. The institution of Dr. Mathews has received research support from Muscular Dystrophy Association . The institution of Dr. Mathews has received research support from Friedreich's Ataxia Research Alliance . The institution of Dr. Mathews has received research support from Sarepta . The institution of Dr. Mathews has received research support from Pfizer. The institution of Dr. Mathews has received research support from Reata . The institution of Dr. Mathews has received research support from PTC Therapeutics, Inc. The institution of Dr. Mathews has received research support from Italfarmaco . The institution of Dr. Mathews has received research support from AMO. The institution of Dr. Mathews has received research support from FibroGen. The institution of Dr. Mathews has received research support from Capricor. The institution of Dr. Mathews has received research support from edgewise. The institution of Dr. Mathews has received research support from biogen.
John Chen	John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Daniel Freedman, DO	Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedStudy. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Stoll Keenon Ogden.
Maria Sunzel, PhD	Dr. Sunzel has received personal compensation for serving as an employee of Teva Pharmaceuticals. Dr. Sunzel has stock in Teva Pharmaceuticals. An immediate family member of Dr. Sunzel has stock in Incyte.
Jennifer Petrillo Billet, PhD	Jennifer Petrillo, 14951 has received personal compensation for serving as an employee of Sage Therapeutics. Jennifer Petrillo, 14951 has received stock or an ownership interest from Sage Therapeutics.
Ladan Bigdeli	Mrs. Bigdeli has nothing to disclose.
Weijun Jin, MD	Dr. Jin has nothing to disclose.
Laura Cacciaguerra, MD, PhD	Dr. Cacciaguerra has nothing to disclose.
Glenn Lesser	No disclosure on file
Yoram Ebrahimi, MD	Dr. Ebrahimi has nothing to disclose.
Diego Silva	Diego Silva has received personal compensation for serving as an employee of BMS. Diego Silva has received stock or an ownership interest from BMS.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Tanya Simuni, MD, FAAN	Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation.
Alessandro Serra, MD	Dr. Serra has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Serra has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Gregorio Spagni	Gregorio Spagni has nothing to disclose.
Gulshan Yunisova, MD	Dr. Yunisova has nothing to disclose.
Ehab Y. Harahsheh, MBBS	Dr. Harahsheh has nothing to disclose.
Kaitlin Seibert, MD	Dr. Seibert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Seibert has received research support from Retirement Research Foundation. The institution of Dr. Seibert has received research support from Center for Healthcare Delivery Science and Innovation. Dr. Seibert has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Eli Lilly. Dr. Seibert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with NeurologyLive.
Yakeel Quiroz, PhD	Dr. Quiroz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Quiroz has received research support from National Institutes of Health. The institution of Dr. Quiroz has received research support from Alzheimer's Association. The institution of Dr. Quiroz has received research support from Mass General Hospital Executive Committee on Research (ECOR). Dr. Quiroz has received intellectual property interests from a discovery or technology relating to health care.
Daniel Gomez Ramos, DO	Dr. Gomez Ramos has nothing to disclose.
Hisham Salahuddin, MD	Dr. Salahuddin has nothing to disclose.
Srikanth Karnati	No disclosure on file
Ping Shi, MD	Dr. Shi has nothing to disclose.
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Anne H. Cross, MD, FAAN	Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech / F. Hoffman la Roche. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb . Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Cross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Consortium of MS Centers. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Cross has received research support from Genentech. Dr. Cross has received intellectual property interests from a discovery or technology relating to health care.
Marie Groth, PhD	Dr. Groth has received personal compensation for serving as an employee of Novartis Pharma GmbH.
Sarah Shapiro	Miss Shapiro has nothing to disclose.
Fumihiro Watanabe	No disclosure on file
Olaf Stuve, MD, PhD, FAAN	Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.
Maira I. Haque	Mrs. Haque has nothing to disclose.
Andreas Horn, MD, PhD	Dr. Horn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Victor W. Henderson, MD, FAAN	Dr. Henderson has stock in Abbott, Amgen, Roche. The institution of Dr. Henderson has received research support from NIH. The institution of Dr. Henderson has received research support from Health IQ. Dr. Henderson has received personal compensation in the range of $500-$4,999 for serving as a External advisory committee member, Alzheimer's Disease Center with University of Kansas. Dr. Henderson has a non-compensated relationship as a adjunct (honorary) professor with Aarhus University that is relevant to AAN interests or activities.
Andrew Liu, MD	Dr. Liu has received personal compensation in the range of $0-$499 for serving as a Consultant for Darwin Research Group.
Evan Huff, MD	Mr. Huff has nothing to disclose.
Jennifer McCombe, MD	Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon therapeutics. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon therapeutics.
Thomas E. Kimber, PhD, FRACP	Dr. Kimber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Kimber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kimber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Kimber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Kimber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Seqiris. Dr. Kimber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Kimber has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Pfizer.
Evis Havari, Msc	Ms. Havari has received personal compensation for serving as an employee of sanofi.
Davorka Tomic	Davorka Tomic has stock in Meck KGaA.
Allison Wright Willis, MD	Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pharmacoepidemiology and Drug Safety. Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Wright Willis has received research support from NIH. The institution of Dr. Wright Willis has received research support from NIA. The institution of Dr. Wright Willis has received research support from Biogen. The institution of Dr. Wright Willis has received research support from Parkinson Foundation. The institution of Dr. Wright Willis has received research support from Arcadia.
James Liao, MD	The institution of Dr. Liao has received research support from American Parkinson Disease Association. The institution of Dr. Liao has received research support from a Cleveland Clinic - IBM Research Collaboration, in the form of in-kind support. Dr. Liao has received intellectual property interests from a discovery or technology relating to health care. Dr. Liao has a non-compensated relationship as a Investigator with Adult Hydrocephalus Research Network that is relevant to AAN interests or activities.
Paul Mehta	Paul Mehta has nothing to disclose.
Harneel S. Saini, DO	Dr. Saini has nothing to disclose.
Jorge Villavicencio	No disclosure on file
Ke Li, MD	Dr. Li has nothing to disclose.
Radu Tanasescu, MD, PhD, FAAN	Dr. Tanasescu has received personal compensation for serving as an employee of Merck. Dr. Tanasescu has received personal compensation for serving as an employee of Novartis. Dr. Tanasescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Tanasescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Tanasescu has received research support from UK MRC grant MR/T024402/1.
Mario Amatruda	No disclosure on file
Michael D. Fox, MD, PhD	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Daniel C. Parker, MD	The institution of Dr. Parker has received research support from NIH.
Jason Sharps	Jason Sharps has nothing to disclose.
Brian J. Hanrahan, MD	Dr. Hanrahan has received personal compensation for serving as an employee of Nowyouknow Neuro.
Mohamed M. Eldokmak, MD	Dr. Eldokmak has nothing to disclose.
Veit Rothhammer, MD	Prof. Rothhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Rothhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Prof. Rothhammer has received research support from German Research Foundation. The institution of Prof. Rothhammer has received research support from European Research Council.
Hanah A. Imam, MBBS	Dr. Imam has nothing to disclose.
Neelu Dhingra, MD	Dr. Dhingra has nothing to disclose.
Sofia Rael, MD	Dr. Rael has nothing to disclose.
Oana M. Dumitrascu, MD, FAAN	Dr. Dumitrascu has nothing to disclose.
Michael Ferguson	Michael Ferguson has nothing to disclose.
Ronak U. Trivedi	Mr. Trivedi has nothing to disclose.
Mason Blacker	No disclosure on file
Chandra Sekhar Mannyam, MBBS	Dr. Mannyam has nothing to disclose.
Hussam A. Yacoub, DO	Dr. Yacoub has nothing to disclose.
Victor H. Salinas	The institution of an immediate family member of Dr. Salinas has received research support from Veterans Health Administration.
Sara W. Hyman	Ms. Hyman has nothing to disclose.
Francois Salachas	No disclosure on file
Grace L. Liang, MD	Dr. Liang has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Liang has stock in Neurocrine Biosciences.
Laurie Wagner	Laurie Wagner has nothing to disclose.
Jim Scott	No disclosure on file
Mónica Jaramillo Castro	Miss Jaramillo Castro has nothing to disclose.
Jonathan Pansieri, PhD	The institution of Dr. Pansieri has received research support from UK-MS society. The institution of Dr. Pansieri has received research support from Department of Defense US. Dr. Pansieri has received personal compensation in the range of $0-$499 for serving as a member of the Grant review Panel with French National Agency. Dr. Pansieri has received personal compensation in the range of $500-$4,999 for serving as a recipee of Travel Grant with Brain.
Wilson E. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Markus Weber, MD	Dr. Weber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Weber has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe.
Andrea Vincent	Andrea Vincent has received personal compensation for serving as an employee of Vista LifeSciences. The institution of Andrea Vincent has received research support from Medical Technology Enterprise Consortium (MTEC).
Parthasarathy Thirumala, MD, FAAN	The institution of Dr. Thirumala has received research support from University of Pittsburgh.
Presley M. Gruezo, Jr.	Mr. Gruezo has nothing to disclose.
Adrian Marchidann, MD	Dr. Marchidann has stock in Eli Lilly. Dr. Marchidann has stock in Pfizer. Dr. Marchidann has stock in Merck. Dr. Marchidann has stock in Illumina. Dr. Marchidann has stock in Aeterna Zentaris. Dr. Marchidann has stock in Abbot. Dr. Marchidann has received publishing royalties from a publication relating to health care. Dr. Marchidann has received publishing royalties from a publication relating to health care.
Mark Versavel, MD, PhD	An immediate family member of Dr. Versavel has received personal compensation for serving as an employee of Cerevel. Dr. Versavel has received personal compensation for serving as an employee of Eliem. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bial. Dr. Versavel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Grunenthal. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alkermes. Dr. Versavel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Versavel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aptinyx. Dr. Versavel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alzheon. Dr. Versavel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Finch. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maplight. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Praxix. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Confo.
Sayyeda Zahra, MD	Dr. Zahra has nothing to disclose.
Lokesh A. Rukmangadachar, MD	Dr. Rukmangadachar has nothing to disclose.
Lars Bergmann, MD	Lars Bergmann has received personal compensation for serving as an employee of Abbvie. Lars Bergmann has stock in Abbvie.
Victor W. Sung, MD	Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Neuroscience. Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Sung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure.
Muhammed Ors	Mr. Ors has nothing to disclose.
Christina Tan, MD	Dr. Tan has nothing to disclose.
Marie Charmaine C. Sy, MD	Marie Charmaine Sy has nothing to disclose.
Jin Myoung Seok, MD	Jin Myoung Seok has nothing to disclose.
Evgeny Sidorov, MD	Dr. Sidorov has nothing to disclose.
Sumita M. Strander	Ms. Strander has nothing to disclose.
Trenley Anderson	Miss Anderson has nothing to disclose.
Zabrina G. Reyes, MD	Ms. Reyes has nothing to disclose.
Alexandra Miner	Miss Miner has nothing to disclose.
Debolina Ghosh	Miss Ghosh has nothing to disclose.
Marcio Souza	Marcio Souza has received personal compensation for serving as an employee of Praxis Precision Medicines.
Monique L. Giroux, MD	Dr. Giroux has received personal compensation for serving as an employee of Praxis Precision Medicine.
Amanda Furtmann	No disclosure on file
Rafael Joao	Mr. Joao has nothing to disclose.
Federico Montini	Mr. Montini has nothing to disclose.
Bernd C. Kieseier, MD	Dr. Kieseier has received personal compensation for serving as an employee of Novartis. Dr. Kieseier has stock in Novartis.
Cordula Weiss, PhD	Dr. Weiss has received personal compensation for serving as an employee of Novartis Pharma GmbH.
Victor Wang, MD	Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Scott Baver	Scott Baver has received personal compensation for serving as an employee of Scholar Rock.
Aparna Ajjarapu	Ms. Ajjarapu has nothing to disclose.
Shubham Misra, PhD	Dr. Misra has nothing to disclose.
Marina Ziehn, PhD	No disclosure on file
Gina L. Hadley, MD	Dr. Hadley has nothing to disclose.
Regina Schlaeger, MD	The institution of Dr. Schlager has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sobi. The institution of Dr. Schlager has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. The institution of Dr. Schlager has received research support from Gottfried and Julia Bangerter Rhyner Foundation. The institution of Dr. Schlager has received research support from Freiwillige Akademische Gesellschaft. The institution of Dr. Schlager has received research support from Stiftung zur Förderung der gastroenterologischen Forschung und allgemeinen Klinischen Forschung sowie der medizinischen Bildgebung. The institution of Dr. Schlager has received research support from Lorenzo Piaggio Foundation. The institution of Dr. Schlager has received research support from Biogen Inc.

��ɫ����

��ɫ����

��ɫ��

��ɫ��